Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

Chinese Herbal Medicine For COVID-19 (Coronavirus) Treatment

China is encouraging herbal remedies to treat COVID-19. But scientists warn against it.

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

The traditional Chinese medicine that could become 'key treatment' for heart attacks, as study finds it lowers inflammation without adverse effects

Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI

Treatment for Mild Chronic Hypertension during Pregnancy

Chinese herbal medicine tongxinluo beneficial for patients with STEMI: CTS-AMI study

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Frontiers Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction

Traditional Chinese medicine Tongxinluo may improve heart health

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality

The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial - ScienceDirect

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease